Quiet Therapeutics Overview

  • Founded
  • 2010
  • Status
  • Out of Business
  • Employees
  • 4
  • Latest Deal Type
  • Liquidation

Quiet Therapeutics General Information


Developer of cancer drugs designed to specifically target tumor cells. The company's drugs utilize its proprietary GAGomer technology that target the specific cancer cells, that leads to the death of the cancer cells, enabling healthcare providers to cure their patients and improve their lives.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Primary Office
  • 18 Einstein Street, 5th floor
  • POB: 4053
  • Ness Ziona 74140
  • Israel
+972 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Quiet Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Liquidation 01-Jan-2017 000.00 Completed Out of Business
3. Early Stage VC (Series A) 01-Apr-2015 0000 000.00 Completed Startup
2. Grant 01-Nov-2013 $2.86M $5.5M Completed Startup
1. Early Stage VC 15-Jan-2013 $5.5M $5.5M Completed Startup
To view Quiet Therapeutics’s complete valuation and funding history, request access »

Quiet Therapeutics Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of cancer drugs designed to specifically target tumor cells. The company's drugs utilize its proprietary GAGom
Drug Delivery
Ness Ziona, Israel
4 As of 2014
000000000000 000.00


ed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nost
0000 000000000
Muttenz, Switzerland
00 As of 0000
000000 0


illum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa
0000 000000000
Uppsala, Sweden
00 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Quiet Therapeutics Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TOLREMO therapeutics Venture Capital-Backed Muttenz, Switzerland 00 000.00 000000 0
00000000 000000000 Venture Capital-Backed Uppsala, Sweden 00 0000000000
000000000 Formerly PE-Backed Planegg, Germany 000 00000 000000000 00000
0000000 Venture Capital-Backed Newhouse, United Kingdom 00 000.00 00000000000 000.00
0000000 0000000000 Formerly VC-backed Brisbane, CA 000 000.00 00000000 000.00
You’re viewing 5 of 5 competitors. Get the full list »

Quiet Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial